Product Information
RAMIPRIL 5 MG CAPSULE is a generic product labeled by BluePoint Laboratories, priced at $0.0514 per EA under NDC 68001043003. Its NADAC has been published 325 times since Jul 15, 2020.
FDA first approved this application on Jun 8, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001043003
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA091604FDA Approved
6/8/2011
TE Code
AB
On Market Since
2/28/2020
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 5 MG CAPSULE has been published 325 times since Jul 15, 2020, and over the history we have for it it has declined 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0514 per EA |
|---|---|
| All-time high | $0.0705 (Sep 14, 2022) |
| All-time low | $0.0411 (Nov 20, 2024) |
| 52-week high | $0.0556 |
| 52-week low | $0.0494 |
| Median price | $0.0557 |
| Average price | $0.0567 |
| Largest weekly change | -18.6% (Jan 17, 2024) |
| Weeks tracked | 325 |
| Tracking since | Jul 15, 2020 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ramipril market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RAMIPRIL 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 5 MG CAPSULE, manufactured by BluePoint Laboratories, is $0.0514 per EA (NDC 68001043003), effective Sep 30, 2026.
How has the price of RAMIPRIL 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 5 MG CAPSULE has declined 25.9%. It has been tracked across 325 weekly CMS publications since Jul 15, 2020.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 5 MG CAPSULE?
Since Jul 15, 2020, the NADAC for RAMIPRIL 5 MG CAPSULE has ranged from a low of $0.0411 (Nov 20, 2024) to a high of $0.0705 (Sep 14, 2022), with a median of $0.0557 per EA.
Are there cheaper alternatives to RAMIPRIL 5 MG CAPSULE?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RAMIPRIL 5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RAMIPRIL 5 MG CAPSULE?
RAMIPRIL 5 MG CAPSULE (NDC 68001043003) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.